Compare JBS N.V. Class A Common Shares (JBS) vs Nexgen Energy Ltd. Common Shares (NXE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
JBS N.V. Class A Common Shares vs Nexgen Energy Ltd. Common Shares — how do they compare? JBS N.V. Class A Common Shares trades at $13 (market cap $13.86B), while Nexgen Energy Ltd. Common Shares trades at $8 (market cap $5.67B). The key difference: JBS N.V. Class A Common Shares is far larger — about 2.4× Nexgen Energy Ltd. Common Shares's market cap, and JBS N.V. Class A Common Shares pays a 10.38% dividend while Nexgen Energy Ltd. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold JBS N.V. Class A Common Shares for 0 Days and Nexgen Energy Ltd. Common Shares for 6 Days on average.
| JBS | NXE | |
|---|---|---|
Market Cap | $13.86B | $5.67B |
Volume | 4,980,049 | 4,335,942 |
Sector | Consumer Staples | Energy |
52-Week High | $18.42 | $13.92 |
52-Week Low | $10.86 | $7.56 |
Typical Hold Time | 0 Days | 6 Days |
Enterprise Value | $34.83B | $5.42B |
Dividend Yield | 10.38% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JBS trades at $12.93, up 0.54% today, with a neutral technical signal and strong analyst buy consensus. The stock shows attractive valuation with a P/E of 12.08 and P/S of 0.47, though recent quarterly EPS misses and a declining profit margin to 1.22% in 2026 highlight earnings pressure. Recent news includes a proposal to acquire full control of Pilgrim's Pride and a joint venture in Southeast Asia, indicating strategic expansion.
The outlook is mixed: analyst targets suggest ~40% upside to $18.17, but risks include execution on acquisitions, margin compression, and volatile beef markets. Cash flow turned positive in 2026 projections, supporting growth initiatives, yet debt levels and competitive pressures warrant caution for investors seeking stability.
NexGen Energy (NXE) trades at $8.47, down 1.28% today, with a bearish technical signal from moving averages despite neutral oscillators. The company shows no current revenue but is advancing its Rook I uranium project targeting first production in 2030. Recent news highlights institutional buying and positive analyst sentiment amid expectations of long-term uranium supply deficits. Financials reflect pre-revenue development stage with negative profitability metrics and significant cash burn.
NXE presents a high-risk, high-potential opportunity as a pure-play uranium developer with strong analyst support but substantial execution risk. The bullish uranium market thesis contrasts with current financial losses and project development timelines. Investment appeal hinges on successful project financing and uranium price sustainability, with near-term volatility expected during construction phase.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About JBS N.V. Class A Common Shares
JBS N.V. is a protein-processing company producing beef, pork, poultry, lamb, fish, and plant-based products, headquartered in São Paulo and Amsterdam. It operates more than 250 production facilities across over 16 countries under brands including Friboi, Seara, Swift, and Pilgrim's, and is the majority shareholder of Pilgrim's Pride Corporation.
Read more on JBS →About Nexgen Energy Ltd. Common Shares
NexGen Energy develops uranium projects in Canada. Its main asset is the Rook I Project in Saskatchewan, which includes the Arrow uranium deposit.
Read more on NXE →
